Abstract
We studied the cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in conscious dogs. Sinus rate, corrected sinus recovery time and Wenckebach point were measured in 6 intact dogs. Atrial rate, ventricular rate and atrial effective refractory period were measured in 6 atrioventricular-blocked dogs. In both groups, we also determined blood pressure and plasma drug concentrations. Each dog received, with at least an 8-day interval, propafenone (hydrochloride) and 5-hydroxypropafenone (hydrochloride) in 4 successive intravenous injections, 30 min apart, at 0.5, 0.5, 1 and 2 mg kg(-1). Propafenone increased sinus rate and atrial rate more markedly than 5-hydroxypropafenone, and also transiently ventricular rate, whereas 5-hydroxypropafenone decreased it weakly. Propafenone shortened corrected sinus recovery time and increased Wenckebach point at the highest dose only, whereas 5-hydroxypropafenone did not modify corrected sinus recovery time and increased Wenckebach point less markedly than propafenone. Both drugs produced an identical atrial effective refractory period lengthening. Propafenone either increased mean blood pressure (in intact dogs) or decreased it (in atrioventricular-blocked dogs) a...Continue Reading
References
Oct 15, 1979·European Journal of Pharmacology·C ChassaingP Duchene-Marullaz
Jun 30, 1978·Deutsche medizinische Wochenschrift·O A BeckH Hochrein
Feb 1, 1991·Journal of Cardiovascular Pharmacology·M BoucherP Duchêne-Marullaz
Aug 1, 1991·Journal of Cardiovascular Pharmacology·T BuddeG Breithardt
May 1, 1991·The American Journal of Cardiology·W E HaefeliF Follath
Jan 1, 1990·The Journal of Emergency Medicine·G BertiniG Moschi
Jul 1, 1990·Canadian Journal of Physiology and Pharmacology·C R Kerr
Sep 1, 1986·Journal of Cardiovascular Pharmacology·J H LiP Duchêne-Marullaz
Nov 1, 1987·Journal of Cardiovascular Pharmacology·C ValenzuelaJ Tamargo
Oct 1, 1988·Journal of Cardiovascular Pharmacology·J P KantelipP Duchene-Marullaz
Oct 1, 1989·Journal of Cardiovascular Pharmacology·R RouetB A Dupuis
Nov 1, 1986·Agents and Actions·J H LiP Duchene-Marullaz
Mar 1, 1987·British Journal of Pharmacology·C DelgadoC Valenzuela
Apr 1, 1987·American Heart Journal·T KatohT Peter
Jul 1, 1987·Pediatric Research·J VillafaneA S Pickoff
Apr 1, 1985·Journal of Pharmacological Methods·M Boucher, P Duchene-Marullaz
Dec 1, 1985·British Journal of Pharmacology·C DelgadoT Tejerina
Jul 1, 1971·Circulation·W MandelH S Marcus
Jan 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·M Kohlhardt, C Seifert
Nov 1, 1981·Journal of Cardiovascular Pharmacology·F LeddaA Mugelli
Dec 1, 1983·The American Journal of Cardiology·S J ConnollyR A Winkle
Aug 1, 1984·American Heart Journal·N de SoyzaH Dinh
Nov 1, 1984·The American Journal of Cardiology·F NaccarellaE Ambrosioni
Apr 1, 1983·Journal of Pharmacological Methods·C DubrayP Duchene-Marullaz
Aug 1, 1982·British Journal of Pharmacology·R J MarshallE Winslow
Jul 9, 1982·Journal of Chromatography·S R Harapat, R E Kates
Oct 1, 1982·British Journal of Pharmacology·P Duchene-MarullazJ P Kantelip
Apr 1, 1994·Journal of Cardiovascular Pharmacology·M BoucherP Duchêne-Marullaz
Dec 15, 1994·Regulatory Peptides·M BoucherP Lorente